|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
1-2
|
|
pubmed:dateCreated |
2010-2-12
|
|
pubmed:abstractText |
There is growing evidence that chronic obstructive pulmonary disease (COPD) is a risk factor for coronary heart disease. Simvastatin is a hypolipemic drug with proven efficacy in the prevention of cardiovascular diseases. Observational studies showed that statins may be useful in the reduction of mortality from COPD. Experimental studies on animals showed anti-inflammatory effects of statins on the lung tissue.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:issn |
1897-9483
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
120
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
11-7
|
|
pubmed:meshHeading |
pubmed-meshheading:20150839-Adult,
pubmed-meshheading:20150839-Aged,
pubmed-meshheading:20150839-Aged, 80 and over,
pubmed-meshheading:20150839-Analysis of Variance,
pubmed-meshheading:20150839-Biological Markers,
pubmed-meshheading:20150839-C-Reactive Protein,
pubmed-meshheading:20150839-Cytokines,
pubmed-meshheading:20150839-Female,
pubmed-meshheading:20150839-Humans,
pubmed-meshheading:20150839-Hydroxymethylglutaryl-CoA Reductase Inhibitors,
pubmed-meshheading:20150839-Interleukin-6,
pubmed-meshheading:20150839-Male,
pubmed-meshheading:20150839-Middle Aged,
pubmed-meshheading:20150839-Pulmonary Disease, Chronic Obstructive,
pubmed-meshheading:20150839-Simvastatin
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
The influence of simvastatin on selected inflammatory markers in patients with chronic obstructive pulmonary disease.
|
|
pubmed:affiliation |
2nd Department of Internal Medicine, Jagiellonian University School of Medicine, Kraków, Poland. przemek.kaczmarek@poczta.fm
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|
